Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mevalonate kinase, putative | 0.0169 | 0.2026 | 0.2026 |
Entamoeba histolytica | galactokinase, putative | 0.0553 | 1 | 1 |
Mycobacterium ulcerans | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0169 | 0.2026 | 0.2026 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0113 | 0.0855 | 0.0855 |
Trichomonas vaginalis | galactokinase, putative | 0.0258 | 0.3859 | 1 |
Brugia malayi | Probable ClpP-like protease | 0.0172 | 0.2088 | 0.5411 |
Mycobacterium ulcerans | galactokinase | 0.0553 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0073 | 0.0026 | 0.0068 |
Onchocerca volvulus | 0.0072 | 0 | 0.5 | |
Trypanosoma brucei | mevalonate kinase, putative | 0.0169 | 0.2026 | 0.33 |
Mycobacterium leprae | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0169 | 0.2026 | 0.9705 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0113 | 0.0855 | 0.0855 |
Trypanosoma brucei | phosphomevalonate kinase protein, putative | 0.0169 | 0.2026 | 0.33 |
Leishmania major | mevalonate kinase, putative | 0.0169 | 0.2026 | 0.2026 |
Brugia malayi | galactokinase family protein | 0.0258 | 0.3859 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0172 | 0.2088 | 1 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.0095 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0172 | 0.2088 | 0.5411 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0073 | 0.0026 | 0.0026 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 1 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0172 | 0.2088 | 0.5 |
Leishmania major | homoserine kinase, putative | 0.0169 | 0.2026 | 0.2026 |
Echinococcus granulosus | N acetylgalactosamine kinase | 0.0258 | 0.3859 | 0.3859 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.2088 |
Schistosoma mansoni | galactokinase | 0.0258 | 0.3859 | 1 |
Trypanosoma cruzi | homoserine kinase | 0.0169 | 0.2026 | 0.2026 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0113 | 0.0855 | 0.0855 |
Trypanosoma brucei | galactokinase-like protein, putative | 0.0368 | 0.6141 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.2088 | 0.5411 |
Echinococcus multilocularis | N acetylgalactosamine kinase | 0.0258 | 0.3859 | 0.3859 |
Leishmania major | phosphomevalonate kinase protein, putative | 0.0169 | 0.2026 | 0.2026 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.5 |
Trypanosoma cruzi | galactokinase-like protein, putative | 0.0482 | 0.8509 | 0.8509 |
Trypanosoma cruzi | homoserine kinase | 0.0169 | 0.2026 | 0.2026 |
Giardia lamblia | Mevalonate kinase | 0.0169 | 0.2026 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0172 | 0.2088 | 0.0336 |
Mycobacterium ulcerans | phosphomevalonate kinase | 0.0169 | 0.2026 | 0.2026 |
Trichomonas vaginalis | galactokinase, putative | 0.0258 | 0.3859 | 1 |
Echinococcus multilocularis | Mevalonate galactokinase | 0.0169 | 0.2026 | 0.2026 |
Mycobacterium ulcerans | mevalonate kinase, Erg12 | 0.0169 | 0.2026 | 0.2026 |
Trichomonas vaginalis | galactokinase, putative | 0.0098 | 0.0535 | 0.1387 |
Treponema pallidum | galactokinase | 0.0482 | 0.8509 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0172 | 0.2088 | 0.0336 |
Toxoplasma gondii | GHMP kinase, N-terminal domain-containing protein | 0.0258 | 0.3859 | 1 |
Schistosoma mansoni | mevalonate kinase | 0.0169 | 0.2026 | 0.5252 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 1 |
Trypanosoma cruzi | galactokinase, putative | 0.0553 | 1 | 1 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.2088 |
Loa Loa (eye worm) | galactokinase | 0.0258 | 0.3859 | 1 |
Leishmania major | galactokinase-like protein | 0.0553 | 1 | 1 |
Mycobacterium tuberculosis | Possible D-alpha-D-heptose-7-phosphate kinase HddA | 0.0169 | 0.2026 | 0.2026 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0113 | 0.0855 | 0.0855 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.2088 |
Trypanosoma cruzi | fucose kinase, putative | 0.0098 | 0.0535 | 0.0535 |
Trichomonas vaginalis | galactokinase, putative | 0.0258 | 0.3859 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 1 |
Echinococcus granulosus | Mevalonate galactokinase | 0.0169 | 0.2026 | 0.2026 |
Brugia malayi | hypothetical protein | 0.0073 | 0.0026 | 0.0068 |
Mycobacterium tuberculosis | Probable galactokinase GalK (galactose kinase) | 0.0553 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0073 | 0.0026 | 0.0026 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0113 | 0.0855 | 0.4094 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.2026 | 0.5252 |
Mycobacterium ulcerans | homoserine kinase | 0.0169 | 0.2026 | 0.2026 |
Trypanosoma cruzi | fucose kinase, putative | 0.0098 | 0.0535 | 0.0535 |
Trypanosoma cruzi | galactokinase, putative | 0.0553 | 1 | 1 |
Trypanosoma cruzi | galactokinase, putative | 0.0482 | 0.8509 | 0.8509 |
Brugia malayi | mevalonate kinase family protein | 0.0169 | 0.2026 | 0.5252 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0172 | 0.2088 | 0.2088 |
Echinococcus multilocularis | galactokinase | 0.0553 | 1 | 1 |
Trichomonas vaginalis | galactokinase, putative | 0.0258 | 0.3859 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0073 | 0.0026 | 0.0068 |
Trypanosoma brucei | homoserine kinase | 0.0169 | 0.2026 | 0.33 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 112.2018 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.